Sema4 SPAC

19 Business Model Evolution: From testing to monetizing a platform of algorithms Increased Value to Patients, Providers, Pharma GENOMIC TESTING SOLUTIONS REVENUE MONETIZE INFORMATION PLATFORM TO QUERY FOR INSIGHTS SECONDARY INSIGHTS Information-rich genomic testing platform Novel disease models that inform clinical care and trials reducing cost and improving outcomes Matching patients to products and services (moving beyond providers and life science) Richness of Data Set & Relationships sema4

View entire presentation